CWM
MRNA icon

Cedar Wealth Management’s Moderna MRNA Stock Holding History

Cedar Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$2.95K – 183
2025
Q4 		$2.95K Hold
100
– – ﹤0.01% 208
2025
Q3 		$2.58K Sell
100
-190
-66% -$5.3K ﹤0.01% 224
2025
Q2 		$8K Hold
290
– – ﹤0.01% 168
2025
Q1 		$8.22K Hold
290
– – ﹤0.01% 148
2024
Q4 		$12.1K Hold
290
– – ﹤0.01% 139
2024
Q3 		$19.4K Hold
290
– – 0.01% 193
2024
Q2 		$34.4K Hold
290
– – 0.01% 176
2024
Q1 		$30.9K Buy
290
+90
+45% +$9.07K 0.01% 186
2023
Q4 		$19.9K Hold
200
– – 0.01% 195
2023
Q3 		$20.7K Buy
+200
New +$22.3K 0.01% 197

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return